Hyperbaric oxygen induces placental growth factor expression in bone marrow-derived mesenchymal stem cells

Life Sciences

Volumn 83, Issue 1-2, 2008, Pages 65-73

  Shyu, Kou Gi ^a,b   Hung, Huei Fong ^a   Wang, Bao Wei ^a   Chang, Hang ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hyperbaric oxygen; Oxidative stress; Reactive oxygen species; Stem cell

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; PLACENTAL GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; WORTMANNIN;

ANGIOGENESIS; ARTICLE; ATMOSPHERE; BONE MARROW CELL; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERBARIC OXYGEN; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELLS; NF-E2 TRANSCRIPTION FACTOR, P45 SUBUNIT; OXYGEN; PREGNANCY PROTEINS; PROTEIN BIOSYNTHESIS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; TRANSCRIPTION, GENETIC;

EID: 45449113728     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.05.005     Document Type: Article

References (39)

1. Abidia A., Laden G., Kuhan G., Johnson B.F., Wilkinson A.R., Renwick P.M., Masson E.A., and McCollum P.T. The role of hyperbaric oxygen therapy in ischemic diabetic lower extremity ulcers: a double-blind randomized controlled trial. European Journal of Vascular and Endovascular Surgery 25 (2003) 513-518
2. Andrews N.C. Molecules in focus: the NF-E2 transcription factor. The International Journal of Biochemistry & Cell Biology 30 (1998) 429-432
3. Autiero M., Luttun A., Tjwa M., and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. Journal of Thrombosis and Haemostasis 1 (2003) 1356-1370
4. Bauer S.M., Goldstein I.J., Bauer R.J., Chen H., Putt M., and Velazquez O.C. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. Journal of Vascular Surgery 43 (2006) 134-141
5. Bouachour G., Cronier P., Gouello J.P., Toulemonde J.L., Talha A., and Alquier P. Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. The Journal of Trauma 41 (1996) 333-339
6. Carmeliet P., Moons L., and Luttun A. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Medicine 7 (2001) 575-583
7. Chang H., Shyu K.G., Wang B.W., and Kuan P. Regulation of hypoxia-inducible factor 1-a by cyclical mechanical stretch in rat vascular smooth muscle cells. Clinical Science 105 (2003) 447-456
8. Chang H., Shyu K.G., Lee C.C., Tsai S.C., Wang B.W., Lee Y.S., and Lin S. GL-331 inhibits HIF-1α expression in a lung cancer model. Biochemical and Biophysical Research Communications 302 (2003) 95-100
9. Cianfarani F., Zambruno G., Brogelli L., Sera F., Lacal P.M., Pesce M., Capogrossi M.C., Failla C.M., Napolitano M., and Odorisio T. Placenta growth factor in diabetic wound healing. Altered expression and therapeutic potential. The American Journal of Pathology 169 (2006) 1167-1182
10. Clauss M., Weich H., Brier G., Knies U., Rock W., Waltenberger J., and Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implication for a function role of placenta growth factor in monocyte activation and chemotaxis. The Journal of Biological Chemistry 271 (1996) 17629-17634
11. Coconi M.T., Baiguera S., Guidolin D., Furlan C., Menti A.M., Vigolo S., Belloni A.S., Parnigotto P.P., and Nussdorfer G.G. Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. Journal of Investigative Medicine 51 (2003) 227-232
12. Fukuda D. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artificial Organs 25 (2001) 187-193
13. Gaallagher K.A., Liu Z.J., Xiao M., Chen H., Goldstein L.J., Buerk D.G., Nedeau A., Thom S.R., and Velazquez O.C. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hypoxia and SDF-1α. The Journal of Clinical Investigation 117 (2007) 1249-1259
14. Gill A.L., and Bell C.A.N. Hyperbaric oxygen in uses, mechanisms of action and outcomes. The Quarterly Journal of Medicine 97 (2004) 385-395
15. Goldstein L.J., Gallagher K.A., Bauer S.M., Bauer R.J., Baireddy V., Liu Z.J., Buerk D.G., Thom S.R., and Velazquez O.C. Endothelial progenitor cell release into circulation is triggered by hyperoxia-induced increases in bone marrow nitric oxide. Stem Cells 24 (2006) 2309-2318
16. Gurdol, F., Cimsit, M., Oner-Iyidogan, Y., Korpinar, S., Yalcinkaya, S., Kocak, H., in press. Early and late effects of hyperbaric oxygen treatment on oxidative stress parameters in diabetic patients. Physiological research.
17. Harabin A.L., Braisted J.C., and Flynn E.T. Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. Journal of Applied Physiology 69 (1990) 328-335
18. Harrison J.E., and Schultz J. Studies on the chlorinating activity of myeloperoxidase. The Journal of Biological Chemistry 251 (1976) 1371-1374
19. + stem cells from bone marrow microenvironment. Nature Medicine 8 (2002) 841-849
20. Haugaard N. Cellular mechanisms of oxygen toxicity. Physiological Reviews 48 (1868) 311-373
21. Heinecke J.W. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Current Opinion in Lipidology 8 (1997) 268-274
22. Inoue N., Kondo T., Kobayashi K., Aoki M., Numaguchi Y., Shibuya M., and Murohara T. Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arteriosclerosis, Thrombosis, and Vascular Biology 27 (2007) 99-105
23. Ishii Y., Miyanaga Y., Shimojo H., Ushida T., and Tateishi T. Effect of hyperbaric oxygen on procollagen on messenger RNA level and collagen synthesis in the healing of rat tendon laceration. Tissue Engineering 5 (1999) 279-286
24. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radical Biology & Medicine 36 (2004) 1199-1207
25. La Van F.B., and Hurt T.K. Oxygen and wound healing. Clinics in Plastic Surgery 17 (1990) 421-432
26. Lee C.C., Chen S.C., Tsai S.C., Wang B.W., Liu Y.C., Lee H.M., and Shyu K.G. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical veins endothelial cells. Journal of Biomedical Science 13 (2006) 143-156
27. Li B., Sharpe E.E., Maupin A.B., Teleron A.A., Pyle A.L., Carmeliet P., and Young P.P. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. The FASEB Journal 20 (2006) E664-676
28. Lin S., Shyu K.G., Lee C.C., Wang B.W., Chang C.C., Liu Y.C., Huang F.Y., and Chang H. Hyperbaric oxygen selectively induces angiopoietin-2 in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 296 (2002) 710-715
29. Marx R.E., Ehler W.J., Tayapongsak P., and Pierce L.W. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. American Journal of Surgery 160 (1990) 519-524
30. McLennan H.R., and Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. Journal of Bioenergetics and Biomembranes 32 (2000) 153-162
31. 164/165 and PlGF. Roles in angiogenesis and arteriogenesis. Trends in Cardiovascular Medicine 13 (2003) 169-175
32. Odorisio T., Cianfarani F., Failla C.M., and Zambruno G. The placenta growth factor in skin angiogenesis. Journal of Dermatological Science 41 (2006) 11-19
33. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
34. Shyu K.G., Wang B.W., Yang Y.H., Tsai S.C., Lin S., and Lee C.C. Amphetamine activates connexin43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. Cardiovascular Research 63 (2004) 98-108
35. Shyu K.G., Wang B.W., Hung H.F., Chang H., and Shih D.T. Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction. Journal of Biomedical Science 13 (2006) 47-58
36. Thom S.R. Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. The New England Journal of Medicine 347 (2002) 1105-1106
37. Thom S.R., Fisher D., Zhang J., Bhopale V.M., Ohnishi S.T., Kotake Y., Ohnishi T., and Buerk D.G. Stimulation of perivascular nitric oxide synthesis by oxygen. American Journal of Physiology. Heart and Circulatory Physiology 284 (2003) H1230-H1239
38. Thom S.R., Bhopale V.M., Velazquez O.C., Goldstein L.J., Thom L.H., and Buerk D.G. Stem cell mobilization by hyperbaric oxygen. American Journal of Physiology. Heart and Circulatory Physiology 290 (2006) H1378-H1386
39. Weissman I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287 (2000) 1442-1446